Search Results
Margetuximab Plus Chemotherapy in HER2+ Breast Cancer
Dr. Pegram on Margetuximab Plus Chemo in HER2+ Breast Cancer
Margetuximab for the treatment of HER2-positive breast cancer
Dr. Rugo on the Phase III SOPHIA Trial in HER2+ Breast Cancer
Study comparing margetuximab combinations to trastuzumab combinations in HER2-positive breast cancer
Margetuximab for the Treatment of HER2+ Breast Cancer
Dr. Blackwell Discusses Margetuximab for HER2+ Breast Cancer
SOPHIA Trial in R/R HER2+ mBC
Episode 341: Pharmacology 101: HER Inhibitors
Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA trials
MAHOGANY: margetuximab in gastric cancer
SOPHIA: Margetuximab and chemo versus trastuzumab and chemo in HER2 positive MBC after prior ant...
